Abstract. Heme oxygenase-1 (HO-1) is induced as an adaptive mechanism against oxidative stress in chondrocytes, which play an important role in the maintenance and degradation of cartilage. In the present study, we examined the role of protein kinase casein kinase (CK2) on peroxynitrite-induced expression of HO-1 in primary articular chondrocytes. 3-Μorpholinosydnonimine hydrochloride (SIN-1) has been shown to mediate cell death by activating apoptosis-related molecules in cells. In this study, we used a low concentration of SIN-1 that did not induce apoptosis to elucidate the mechanism by which SIN-1 upregulates HO-1 expression. In chondrocytes, SIN-1 induced HO-1 expression with spontaneous downregulation in a different manner than with high concentrations of SIN-1. Importantly, SIN-1 treatment of chondrocytes increased CK2 activation. Additionally, inhibition of CK2 with 4,5,6,7-tetrabromobenzotriazole (TBB) or siRNA did not induce HO-1 expression and reduced NF-E2-related factor 2 (Nrf2) accumulation in chondrocytes. Therefore, we examined whether CK2 directly regulates Nrf2, which is a transcription factor that regulates the expression of HO-1. Indeed, TBB treatment inhibited phosphorylation and nuclear translocation of Nrf2 in SIN-1-treated cells. Moreover, using an immunoprecipitation assay, we confirmed that SIN-1 treatment enhanced the interaction between CK2 and Nrf2. Taken together, our findings suggest that peroxynitrite activates Nrf2 via CK2 signaling, leading to the upregulation of HO-1 in primary chondrocytes.
Introduction
Heme oxygenase-1 (HO-1) catabolizes heme to form carbon monoxide, free iron, and biliverdin (1) . These metabolic products play important roles in both physiology and pathology (2, 3) . In general, HO-1 is thought to protect cells and tissues from oxidative stress-induced damage (2, 4) . HO-1 is also anti-inflammatory, antiproliferative, and antiapoptotic through modulating gene expression and enzymatic activities (5) (6) (7) . Recent reports suggest that the induction of HO-1 results in the downregulation of catabolic enzymes and inflammatory mediators in chondrocytes; this in turn suggests a role for HO-1 in the defense systems of articular cartilage (8, 9) .
HO-1 is strongly induced by a variety of stimuli such as inflammatory cytokines, ultraviolet radiation, heme, and heavy metals. The HO-1 promoter contains several transcriptional regulatory elements that respond to redox-sensitive transcription factors. NF-E2-related factor 2 (Nrf2) is the main factor regulating transcriptional activation of HO-1 (10). Nrf2's activity is tightly regulated by its interaction with the actin-binding protein Keap1, a negative modulator of Nrf2 (11) . Nrf2 phosphorylation leads to dissociation with Keap1 in the cytosol and nuclear localization of Nrf2. It has reported that phosphatidylinositol 3-kinase (PI3K) and extracellular signal-regulated kinase (ERK) regulate Nrf2 activation in stress-induced cells (12, 13) .
Protein kinase CK2, formerly called casein kinase 2, is a ubiquitous and highly conserved serine/threonine protein kinase consisting of 2 catalytic subunits (αα, αα' , α'α') and 2 regulatory β subunits (14) . CK2 is a pleiotropic kinase with more than 300 substrates (15) . Consequently, CK2 is involved in multiple metabolic events. CK2 is found in the nucleus, cytoplasm, and organelles such as Golgi, ribosomes, and endoplasmic reticulum (16) . Substantial evidence suggests that CK2 plays important roles in the regulation of cell proliferation, transformation, and apoptotic death (14, (17) (18) (19) (20) as well as in pathological conditions (21) . However, the mechanism by which CK2 regulates its activity and substrates remains largely unknown. It has been reported that CK2 plays a potential role in Nrf2 activation and degradation (22) (23) (24) . However, to date, no studies have examined whether CK2 directly affects HO-1 gene expression.
Herein, we report that CK2 regulates peroxynitrite-induced HO-1 expression in primary rat articular chondrocytes. We also demonstrate a possible role for the CK2 signaling pathway in the activation of Nrf2 to regulate HO-1 expression.
Materials and methods
Reagents. 3-Morpholinosydnonimine hydrochloride (SIN-1), 5,6-dichlorobenzimidazole riboside (DRB), 4,5,6,7-tetrabromobenzotriazole (TBB), protease inhibitor cocktail, trypan blue (0.4%), collagenase and paraformaldehyde were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium (DMEM) and other culture reagents were purchased from Hyclone (Logan, UT, USA). Anti-HO-1, Nrf2, CK2α, and β-actin antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-p-CK2α antibody was purchased from Abcam (Cambridge, MA, USA). The horseradish peroxidase (HRP)-conjugated secondary antibody and the enhanced chemiluminescence (ECL) western blotting kit were obtained from Amersham Pharmacia Biotech (Piscataway, NJ, USA).
Cell culture of articular chondrocytes. Articular chondrocytes for primary culture were isolated from slices of knee-joint cartilage from 5-week-old female Sprague-Dawley rats (Samtako Co., Korea). Chondrocytes were isolated by enzymatic digestion for 1 h with 0.2% type II collagenase in DMEM. After collection of chondrocytes by brief centrifugation, cells were resuspended in DMEM supplemented with 10% heat-inactivated FBS and antibiotics (50 U/ml of penicillin and 50 µg/ml of streptomycin) at 37˚C in an atmosphere of 5% CO 2 and air. Cells were plated on culture dishes at a density of 5x10 4 Western blot analysis. Equal amounts (20 µg) of total proteins were loaded onto 12% SDS-polyacrylamide gels for electrophoresis. The proteins were then transferred to a nitrocellulose membrane using an electroblotting apparatus (Bio-Rad, Richmond, CA), and the membranes were incubated with each primary antibody. Blots were incubated with an HRP-conjugated anti-rabbit secondary antibody. The membranes were developed with the ECL reaction system and visualized using the LAS-3000 Luminescent Image Analyzer (FujiFilm, Japan). Image Gauge Ver. 3.0 software was used to calculate differences in protein expression. β-actin was used as an internal control to monitor equal protein loading.
CK activity assay. CK2 activity was measured in cell lysates with a CK2 assay kit (CycLex Co., Japan) according to the manufacturer's recommended protocol. Kinase activity was calculated by subtracting the mean of the background control samples without enzyme from the mean of samples with enzyme.
Transfection of siRNA. A 21-nucleotide RNA duplex with 3'-dTdT overhangs was designed to interfere exclusively with rat CK2α mRNA (Dharmacon, Lafayette, CO, USA) in the 'ready-to-use' option. A negative control siRNA was also provided by Dharmacon. CK2α siRNA was introduced into chondrocytes using the DharmaFECT ® DUO transfection reagent according to the manufacturer's instruction.
Immunofluorescence staining. Chondrocytes were cultured on collagen-coated 4-well glass chamber slides for 48 h in DMEM containing 10% FBS. Cells were fixed in 4% paraformaldehyde/PBS followed by permeabilization in 0.2% Triton X-100/PBS. Appropriate primary antibodies were added to the cells for 30 min at 37˚C. For secondary labeling, cells were incubated with a FITC-conjugated secondary antibody (Invitrogen) for 30 min at 37˚C. Nuclei were counterstained using propidium iodide (PI). Fluorescent images were visualized and analyzed with a laser-scanning confocal microscope.
Immunoprecipitation. Cell lysates were incubated with protein A-sepharose beads at 4˚C for 30 min. Following incubation, beads and non-specific proteins were removed, and the cleared supernatant was incubated with a monoclonal antibody against CK2α. After incubation for 1 h, immune complexes were captured by protein A-sepharose. Immunoprecipitates were washed with 1% Triton X-100/PBS several times, and proteins were then released by boiling in SDS sample buffer.
Statistics or reproducibility. Each experiment was repeated at least 3 times. Data are expressed as the means ± standard error (SE) from each independent experiment. Data for the experimental and control groups were tested for statistical significance by a one-tailed Student's t-test. P<0.05 denoted statistically significant differences.
Results

Low concentration of SIN-1 induces HO-1 expression without
inducing apoptosis in primary rat chondrocytes. SIN-1 is a peroxynitrite generator and simultaneously produces NO and superoxide. At high concentrations, SIN-1 can induce apoptotic cell death in many cell types. Therefore, the present study aimed to elucidate the exact mechanism of SIN-1 on HO-1 upregulation. SIN-1 dose-dependently upregulated HO-1 expression in primary chondrocytes (Fig. 1A) . However, SIN-1 exposure also significantly increased the number of TUNELpositive chondrocytes (Fig. 1B) . Therefore, the present study used a low concentration of SIN-1 that did not cause apoptosis in order to induce expression of HO-1 in primary rat articular chondrocytes. SIN-1 (200 µM) induced HO-1 expression with spontaneous downregulation in chondrocytes in a different manner than high concentrations of SIN-1 (Fig. 1C) . SIN-1-induced HO-1 expression was inhibited by the NO scavenger, carboxy-PTIO and the superoxide dismutase (SOD) mimetic, TEMPOL in chondrocytes (Fig. 1D ). This suggests that the effect of SIN-1 is caused by generation of peroxynitrite and that SIN-1 is a peroxynitrite donor. Finally, it was demonstrated that peroxynitrite induces the expression of Nrf2 and HO-1 in primary chondrocytes (Fig. 1E) . These results indicate that the induction of HO-1 expression by SIN-1 was due to NO-mediated peroxynitrite rather than NO in primary rat chondrocytes.
Inhibition of CK2 activity prevents SIN-1-induced HO-1 expression.
To determine whether CK2 activity is associated with HO-1 expression in chondrocytes, the effects of CK2 inhibitors, TBB or DRB, on SIN-1-induced HO-1 expression were examined. Indeed, pretreatment with the CK2 inhibitor completely abolished SIN-1-induced HO-1 expression in chondrocytes ( Fig. 2A) . To confirm a specific effect of CK2 on SIN-1-induced HO-1 expression, CK2 was silenced using siRNA. Chondrocytes were transfected with a CK2 siRNA duplex or with a non-specific control for 24 h. Cells were then incubated with SIN-1 or vehicle for another 6 h. Transfection with the control siRNA did not significantly affect HO-1 protein levels relative to non-transfected controls (data not shown). As determined by western blot analysis, CK2 protein expression was markedly reduced in the CK2 siRNA-transfected chondrocytes. Similarly, siRNA efficiently silenced CK2 gene expression and completely suppressed CK2 levels (Fig. 2B) . Importantly, knockdown of CK2 significantly decreased HO-1 expression induced by SIN-1. This suggests that CK2 activation is necessary for SIN-1-induced HO-1 expression in chondrocytes.
SIN-1 stimulates CK2 activity in chondrocytes.
Next, the direct effect of SIN-1 on CK2 activity in chondrocytes was investigated using a CK2 activity assay. Because Nrf2 expression was detected 3 h after SIN-1 treatment (Fig. 1C) , the CK2 activity assay was performed on lysates from chondrocytes treated with SIN-1 for 0.5, 1 and 3 h. After SIN-1 treatment, CK2 activity increased, peaked after 1 h, and then declined (Fig. 3A) . In addition, SIN-1 significantly induced phosphorylation of CK2α, the catalytic subunit of the CK2 heterotetramer, in chondrocytes (Fig. 3B) . TBB completely abrogated phosphorylation of CK2 by SIN-1. The effect of SIN-1 on CK2 activity was also determined using CK2 siRNA. Knockdown of CK2 significantly decreased CK2 activity induced by SIN-1 (Fig. 3C ). This suggests that SIN-1directly stimulates the enzymatic activity of CK2 in chondrocytes.
CK2 induces HO-1 expression via Nrf2 activation in SIN-treated chondrocytes.
To directly test whether CK2 interacts with Nrf2, a complementary set of immunoprecipitation and western blot analyses were performed. Chondrocytes were treated with SIN-1 for 1 h, and the cells were immunoprecipitated with a CK2α antibody and then detected with an antibody against Nrf2. Nrf2 was co-immunoprecipitated with CK2α (Fig. 4A) . Therefore, it was examined whether CK2 activation changes nuclear translocation of Nrf2 in chondrocytes stimulated with SIN-1. Cells were treated with SIN-1 for 3 h in the absence or presence of TBB. Then, cytoplasmic and nuclear extracts were analyzed by western blot analysis. The CK2 inhibitor TBB completely abrogated SIN-1-induced nuclear translocation of Nrf2 to induce HO-1 expression (Fig. 4B) . To this end, nuclear translocation of Nrf2 was determined by two-color analysis under confocal microscopy. In unstimulated cells, Nrf2 was detected in the cytoplasm (green fluorescence) but not in the nucleus, which was stained red by PI (Fig. 4C) . At this time, CK2 expression was not changed by SIN-1 under these experimental conditions. However, when chondrocytes were incubated with SIN-1, there was a significant increase in nuclear translocation of Nrf2, which is in correlation with the cytoplasmic and nuclear distribution of Nrf2. TBB completely blocked the nuclear accumulation of Nrf2 induced by SIN-1. These results suggest that CK2 stimulates Nrf2 activation, which causes an increase in HO-1 expression in SIN-1-treated chondrocytes.
Discussion
HO-1 is a tightly-regulated antioxidant enzyme that is induced as an adaptive mechanism against reactive oxygen species (ROS) in many cell types, including chondrocytes (25) . Numerous studies have documented that NO is a potent inducer of HO-1 in various cell types, and the induction of HO-1 by NO donors occurs predominantly via a transcriptional mechanism (26) (27) (28) . NO has a negligible role in mediating HO-1 expression induced by NO donors, such as sodium nitroprusside (SNP), which produces NO and iron (29, 30) . In addition, it has been demonstrated that some NO donors can induce apoptotic cell death in many cell types (31) (32) (33) (34) . Further, the HO system has been reported to protect against the cytotoxic effects of high-concentration NO donors (35) . Therefore, in the present study, we used a low concentration of SIN-1 to induce HO-1 expression without inducing apoptosis in primary rat chondrocytes.
On the other hand, NO generated through reacting with endogenous superoxide also leads to the formation of peroxynitrite, a short-lived and damaging oxidant that may have diverse negative effects on important biological molecules (36) . Therefore, cells exposed to exogenous NO donors generate peroxynitrite because NO diffuses easily through membranes, and superoxide is constitutively produced in mitochondria under normal conditions. Furthermore, NO can counteract the actions of MnSOD and cytochrome oxidase, which increases superoxide production and peroxynitrite formation (37) . Due to the multiple actions of NO donors, the exact mechanism underlying NO-induced HO-1 expression has yet to be clarified.
Nrf2 is the main transcription factor activating the HO-1 gene. Under unstimulated conditions, Nrf2 is present in the cytosol complexed with Keap1, which is a negative modulator of Nrf2's nuclear translocation. Oxidative stressinduced modification of Keap1 results in Nrf2 release; Nrf2 then translocates into the nucleus. Many reports have demonstrated the roles of PI3K and mitogen-activated protein kinases (MAPKs) for nuclear translocation of Nrf2 (12, 13, 38) . However, this proposed mechanism remains controversial. Recently, CK2-mediated sequential phosphorylation was demonstrated to play a potential role in Nrf2 activation and degradation (22, 23) . Therefore, the present study examined whether CK2 activity is directly associated A low concentration of SIN-1 (200 µM) induced HO-1 expression with spontaneous downregulation in primary rat chondrocytes. Further, our data showed that SIN-1-induced expression of HO-1 was inhibited by the NO scavenger, carboxy-PTIO and the SOD mimetic, TEMPOL, in chondrocytes. We note that this is in contrast to a previous report showing that SIN-1-induced HO-1 expression was inhibited by an NO scavenger but not by SOD in arterial endothelial cells (39) . Moreover, induction of HO-1 by SIN-1 was completely abrogated by the peroxynitrite scavenger, MnTBAP, in a concentration-dependent manner (data not shown). This suggests that induction of HO-1 by SIN-1 is due to peroxynitrite rather than NO in primary rat chondrocytes. Next, we investigated the involvement of the CK2 signaling pathway on SIN-1-induced expression of HO-1. Blockade of CK2 using a specific inhibitor or siRNA markedly decreased HO-1 expression induced by SIN-1 in chondrocytes. Additionally, SIN-1 treatment induced the phosphorylation and activity of CK2, which increased and peaked 1 h after treatment and declined thereafter. We also examined whether SIN-1 activates Nrf2 via CK2 signaling, which leads to induction of HO-1 expression. Importantly, CK2 activation directly stimulated the phosphorylation and nuclear translocation of Nrf2 in chondrocytes stimulated with SIN-1.
Articular cartilage destruction is a key pathological characteristic of osteoarthritis. Recently, it has been reported that HO-1 induction by low doses of sodium nitroprusside can protect against apoptosis induced by high doses of SNP in human chondrocytes (40) . These authors also suggested that inhibition of HO-1 activity significantly increased NO donorinduced cytotoxicity in chondrocytes. Thus, it is important to elucidate the regulation and function of HO-1 in articular diseases. Furthermore, this study raises the interesting possibility that HO-1 may be a potential therapy for diseases associated with apoptotic cell death. For this reason, it is important to identify the precise role of HO-1 in the maintenance and cell death of chondrocytes in articular cartilage. 
